Artivion share price today

(AORT)

Artivion share price is $27.84 & ₹2,388.95 as on 7 Jan 2025, 2.30 'hrs' IST

$27.84

▲

-0.04

(-0.14%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Artivion share price in Dollar and Rupees. Guide to invest in Artivion stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Artivion, along with analyst recommendations, forecasts, and comprehensive financials.

Artivion share price movements

Today's Low: $27.80
Today's High: $28.42
$27.84
0.14%
Downside
Day's Volatility :2.18%
Upside
2.04%
52 Weeks Low: $16.48
52 Weeks High: $30.45
$27.84
40.79%
Downside
52 Weeks Volatility :45.86%
Upside
8.57%

Artivion Returns

Period	Artivion Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	8.48%	-8.4%	0.0%
6 Months	7.81%	-3.8%	0.0%
1 Year	55.23%	-0.1%	0.0%
3 Years	37.07%	2.9%	-19.8%

Artivion Key Statistics

in dollars & INR

Previous Close	$27.88
Open	$27.85
Today's High	$28.42
Today's Low	$27.8
Market Capitalization	$1.2B
Today's Volume	$222.2K
52 Week High	$30.45
52 Week Low	$16.4842
Revenue TTM	$384.9M
EBITDA	$52.6M
Earnings Per Share (EPS)	$-0.03
Profit Margin	-0.22%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-0.29%

How to invest in Artivion from India?

It is very easy for Indian residents to invest directly in Artivion from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Artivion stock in both Indian Rupees (INR) and US Dollars (USD). Search for Artivion or AORT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Artivion or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Artivion shares which would translate to 0.031 fractional shares of Artivion as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Artivion, in just a few clicks!

Returns in Artivion for Indian investors in Rupees

Investment Value

₹1,00,000

Artivion investment value today

Current value as on today

₹1,58,234

Returns

₹58,234

(+58.23%)

Returns from Artivion Stock

₹55,011 (+55.01%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Artivion

-38%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Artivion on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -38% less investors are searching Artivion in the last 30 days versus the previous period.

Global Institutional Holdings in Artivion

BlackRock Inc
15.83%
Vanguard Group Inc
6.69%
Perceptive Advisors LLC
6.66%
Macquarie Group Ltd
6.55%
Morgan Stanley - Brokerage Accounts
5.85%
Juniper Investment Co, LLC
5.01%

Analyst Recommendation on Artivion

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Artivion(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Artivion

What analysts predicted

Upside of 19.13%

Current:

$27.84

Target:

$33.17

Insights on Artivion

Price Movement
In the last 7 days, AORT stock has moved down by -2.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 98.01M → 95.77M (in $), with an average decrease of 2.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 7.53M → -2.28M (in $), with an average decrease of 68.1% per quarter
AORT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 82.1%

Artivion Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$262.8M	↑ 38.55%
Net Income	$-3.8M	↓ 202.73%
Net Profit Margin	-1.45%	↓ 3.4%

	FY19	Y/Y Change
Revenue	$276.2M	↑ 5.09%
Net Income	$1.7M	↓ 145.2%
Net Profit Margin	0.62%	↑ 2.07%

	FY20	Y/Y Change
Revenue	$253.2M	↓ 8.32%
Net Income	$-16.7M	↓ 1069.88%
Net Profit Margin	-6.59%	↓ 7.21%

	FY21	Y/Y Change
Revenue	$298.8M	↑ 18.01%
Net Income	$-14.8M	↓ 11.08%
Net Profit Margin	-4.96%	↑ 1.63%

	FY22	Y/Y Change
Revenue	$313.8M	↑ 5.0%
Net Income	$-19.2M	↑ 29.38%
Net Profit Margin	-6.12%	↓ 1.16%

	FY23	Y/Y Change
Revenue	$354.0M	↑ 12.82%
Net Income	$-30.7M	↑ 59.91%
Net Profit Margin	-8.67%	↓ 2.55%

	Q2 FY23	Q/Q Change
Revenue	$89.3M	↑ 7.24%
Net Income	$-3.4M	↓ 75.01%
Net Profit Margin	-3.79%	↑ 12.47%

	Q3 FY23	Q/Q Change
Revenue	$87.9M	↓ 1.57%
Net Income	$-9.8M	↑ 189.8%
Net Profit Margin	-11.16%	↓ 7.37%

	Q4 FY23	Q/Q Change
Revenue	$93.7M	↑ 6.62%
Net Income	$-4.0M	↓ 59.44%
Net Profit Margin	-4.24%	↑ 6.92%

	Q1 FY24	Q/Q Change
Revenue	$97.4M	↑ 4.02%
Net Income	$7.5M	↓ 289.51%
Net Profit Margin	7.73%	↑ 11.97%

	Q2 FY24	Q/Q Change
Revenue	$98.0M	↑ 0.6%
Net Income	$-2.1M	↓ 128.1%
Net Profit Margin	-2.16%	↓ 9.89%

	Q3 FY24	Q/Q Change
Revenue	$95.8M	↓ 2.29%
Net Income	$-2.3M	↑ 8.08%
Net Profit Margin	-2.39%	↓ 0.23%

	FY18	Y/Y Change
Profit	$173.0M	↑ 34.47%

	FY19	Y/Y Change
Profit	$183.0M	↑ 5.8%

	FY20	Y/Y Change
Profit	$167.8M	↓ 8.32%

	FY21	Y/Y Change
Profit	$197.5M	↑ 17.72%

	FY22	Y/Y Change
Profit	$202.5M	↑ 2.54%

	FY23	Y/Y Change
Profit	$229.2M	↑ 13.16%

	Q2 FY23	Q/Q Change
Profit	$58.1M	↑ 8.11%

	Q3 FY23	Q/Q Change
Profit	$56.3M	↓ 3.12%

	Q4 FY23	Q/Q Change
Profit	$61.1M	↑ 8.57%

	Q1 FY24	Q/Q Change
Profit	$59.1M	↓ 3.3%

	Q2 FY24	Q/Q Change
Profit	$59.4M	↑ 0.49%

	Q3 FY24	Q/Q Change
Profit	$61.0M	↑ 2.76%

	FY18	Y/Y Change
Operating Cash Flow	$9.9M	↓ 8.53%
Investing Cash Flow	$-6.7M	↓ 96.07%
Financing Cash Flow	$-2.6M	↓ 101.79%

	FY19	Y/Y Change
Operating Cash Flow	$15.8M	↑ 60.18%
Investing Cash Flow	$-23.9M	↑ 256.56%
Financing Cash Flow	$-1.5M	↓ 41.73%

	FY20	Y/Y Change
Operating Cash Flow	$12.4M	↓ 21.85%
Investing Cash Flow	$-73.1M	↑ 205.43%
Financing Cash Flow	$93.6M	↓ 6369.79%

	FY21	Y/Y Change
Operating Cash Flow	$-2.6M	↓ 120.9%
Investing Cash Flow	$5.7M	↓ 107.74%
Financing Cash Flow	$-12.2M	↓ 113.06%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↑ 99.34%
Investing Cash Flow	$-10.7M	↓ 289.31%
Financing Cash Flow	$-1.6M	↓ 86.59%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$6.9M	↓ 212.27%
Investing Cash Flow	$7.1M	↑ 0.0%
Financing Cash Flow	$2.2M	↑ 90.69%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.2M	↑ 4.68%
Investing Cash Flow	$-2.1M	↓ 129.22%
Financing Cash Flow	$-909.0K	↓ 140.71%

Artivion Technicals Summary

Sell

Neutral

Buy

Artivion is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Artivion Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Artivion Inc	-3.86%	7.81%	55.23%	37.07%	-0.78%
Stryker Corporation	-5.14%	7.73%	20.51%	37.02%	70.83%
Boston Scientific Corp.	2.22%	18.53%	55.24%	113.84%	98.4%
Edwards Lifesciences Corp.	4.25%	-20.93%	-2.33%	-38.47%	-5.21%
Abbott Laboratories	-0.93%	11.99%	1.27%	-15.84%	31.69%
Medtronic Plc	-3.59%	5.29%	-6.49%	-23.36%	-31.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Artivion Inc	NA	NA	181.5	0.29	0.0	0.02	NA	7.27
Stryker Corporation	38.59	38.59	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.82	73.82	1.62	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.0	28.0	6.67	2.54	0.19	0.11	NA	16.18
Abbott Laboratories	34.38	34.38	2.19	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.43	24.43	1.46	5.45	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Artivion Inc	Buy	$1.2B	-0.78%	NA	-0.22%
Stryker Corporation	Buy	$137.3B	70.83%	38.59	16.34%
Boston Scientific Corp.	Buy	$131.6B	98.4%	73.82	11.26%
Edwards Lifesciences Corp.	Buy	$43.6B	-5.21%	28.0	65.86%
Abbott Laboratories	Buy	$196.2B	31.69%	34.38	13.99%
Medtronic Plc	Buy	$102.4B	-31.62%	24.43	12.06%

About Artivion

cryolife, headquartered in georgia, is a leader in the processing and distribution of human tissues for use in cardiac and vascular surgeries. cryolife using its proprietary synergraft® technology processes the cryovalve® sg pulmonary heart valve and cryopatch® sg pulmonary cardiac patch. cryolife’s bioglue® surgical adhesive is approved in the u.s. for use as an adjunct to sutures and staples to help control bleeding, ce marked in the european community, approved in canada and australia for use in soft tissue repair, and in japan for use in the repair of aortic dissections. cryolife’s cardiogenesis specializes in the treatment of severe angina using a laser console system and fiber-optic handpieces to perform a surgical procedure known as transmyocardial revascularization (tmr). cryolife markets the hero® graft, which provides vascular access for hemodialysis patients. cryolife distributes perclot®, an absorbable powdered hemostat, in international markets. cryolife’s biofoam® surgica

Organization	Artivion
Employees	1500
CEO	Mr. James Patrick Mackin
Industry	Healthcare

Management People of Artivion

Name	Title
Mr. James Patrick Mackin	Chairman, President & CEO
Mr. Lance A. Berry CPA	Executive VP of Finance, COO & CFO
Ms. Amy D. Horton CPA	VP & Chief Accounting Officer
Ms. Jean F. Holloway Esq.	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
Mr. John E. Davis	Senior VP & Chief Commercial Officer
Mr. Matthew A. Getz	VP of Human Resources & Chief Human Resources Officer
Dr. Marshall S. Stanton M.D.	Senior VP of Clinical Research & Chief Medical Officer
Dr. Robert C. Thomson	Vice President of Research & Development
Mr. Florian Tyrs	Vice President of Global Operations

Important FAQs about investing in Artivion from India :

What is Artivion share price today?

Artivion share price today stands at $27.84, Open: $27.85 ; Previous Close: $27.88 ; High: $28.42 ; Low: $27.80 ; 52 Week High: $30.45 ; 52 Week Low: $16.48. The stock opens at $27.85, after a previous close of $27.88. The stock reached a daily high of $28.42 and a low of $27.80, with a 52-week high of $30.45 and a 52-week low of $16.48.

Can Indians buy Artivion shares?

Yes, Indians can invest in the Artivion (AORT) from India.

With INDmoney, you can buy Artivion at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Artivion at zero transaction cost.

How can I buy Artivion shares from India?

It is very easy to buy Artivion from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Artivion be purchased?

Yes, you can buy fractional shares of Artivion with INDmoney app.

What are the documents required to start investing in Artivion stocks?

To start investing in Artivion, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.